For the first time in 20 years, the Food and Drug Administration has approved a new pharmaceutical approach to treating pain.
The U.S. Food and Drug Administration (FDA) approved Thursday a new type of prescription pain medication for moderate to ...
The drug, shown to be almost as effective as opioids for short-term pain, is the first fundamentally new kind of painkiller ...
The new non-opioid drug has been approved for the treatment of severe pain, such as that following surgery or an injury.
The FDA's approval of the non-addictive painkiller Journavx last week marked a milestone in the field of pain management. Why ...
Dr. Sanjay Gupta said Tuesday that the approval of a new non-opioid pain medication is “a pretty big deal.” “This is a pretty ...
If the attention generated by BioSpace’s coverage of this landmark approval is any indication, Americans are hungry for non-opioid pain treatments that could help quell the still raging opioid ...
The Food and Drug Administration announced the approval of a new non-opioid pain medication this week, marking the first time ...
Journavx, a new non-opioid pain medication, offers a safer alternative for managing acute pain while reducing the risk of ...
The U.S. Food and Drug Administration (FDA) approved Journavx (suzetrigine) oral tablets on Thursday as a first-in-class ...
Shares of Vertex Pharmaceuticals gained about 6% Friday morning, after the pharmaceutical company won U.S. approval for the ...
On Thursday, Jan. 30, The U.S. Food and Drug Administration announced that it has approved a new non-opioid painkiller pill from Vertex Pharmaceuticals called suzetrigine, which is being sold ...